You are here

Article info

Article menu
Download PDFPDF
Unexpected outcome (positive or negative) including adverse drug reactions
CASE REPORT
DPP-4 inhibitor (sitagliptin)-induced seronegative rheumatoid arthritis

Authors

  1. Correspondence to Dr Marc Kesselman, mkesselman{at}nova.edu
View Full Text

Citation

Padron S, Rogers E, Demory Beckler M, et al
DPP-4 inhibitor (sitagliptin)-induced seronegative rheumatoid arthritis
BMJ Case Reports CP 2019;12:e228981.

Publication history

  • Accepted July 12, 2019
  • First published August 22, 2019.
Online issue publication 
January 25, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.